Novogen is developing new


therapies for cancer that have the potential to make a significant impact

Novogen is a global biotechnology company dedicated to creating sustainable long-term shareholder value through the discovery and development of signifcant new therapies for patients with cancer.

  • News

    19 October 2016New

    Annual Report for the year ended 30 June 2016Read more

    17 October 2016New

    Notice of Annual General MeetingRead more

    27-28 September 2016New

    16th Annual Biotech in Europe Forum for Global Partnering & Investment in Basel, Switzerland

    More News

  • Upcoming Events

    24-26 October 2016

    AusBiotech 2016 (Australia Biotech Invest) in Melbourne, Victoria

    Dr James Garner, CEO of Novogen, will present a corporate update on the Novogen business.

    7 NOVEMBER 2016

    RACI Medicinal Chemistry and Chemical Biology Conference 2016 in Coogee, New South Wales

    Dr Eleanor Eiffe, Drug Discovery Program Manager, will present on Anisina.

    14-16 NOVEMBER 2016

    World Pre-clinical Congress in Lisbon, Portugal

    Dr Eleanor Eiffe is presenting a Poster on Cantrixil Chemistry.

    More Events

  • Scientific Advisory Board

    Novogen appoints an international Scientific Advisory Board of oncology experts

    Read more

  • Share Price

    Historical Prices